If you are asking where to get stem cell therapy for MS, start with a neurologist who specializes in multiple sclerosis—not a treatment advertisement. The phrase “stem cell therapy” can describe very different approaches, and the right place to ask about a specific option depends on the treatment, your MS history, and the strength of the evidence.

Where should you start looking for stem cell therapy for MS?
Start with your current neurologist or an MS-focused neurologist. Ask whether a stem-cell approach is appropriate for your situation, what kind of treatment is being discussed, and whether you should be evaluated at a specialist center. A center with specific experience in MS and the treatment under consideration is more relevant than a provider that uses the broad label “stem cell therapy.”
For some people with MS, the term may refer to autologous hematopoietic stem cell transplantation, often shortened to aHSCT. This is a specialized medical procedure involving a patient’s own blood-forming stem cells, and it is not the same as an infusion of mesenchymal stromal/stem cells (MSCs), umbilical-cord-derived cells, or exosomes. The National Multiple Sclerosis Society says aHSCT should be received at an accredited center and offers a navigator for general information about the treatment: its aHSCT information page.
Do not use the word “stem cell” alone to decide whether two clinics offer the same treatment. Ask for the exact procedure name, the type and source of cells, who performs each part of care, and the medical team’s experience treating MS. If the answer is vague, pause and ask your neurologist to help interpret it.
A practical first step is to bring the provider’s written description to your neurologist and ask whether it describes a recognized treatment pathway, a research approach, or a different service. If your neurologist recommends specialist evaluation, ask for the name of the relevant center and whether it evaluates people with your type of MS and treatment history. A referral is also a chance to confirm what records the center needs before an appointment, rather than paying for travel or an assessment before you know whether it can address your medical question.
What types of treatment might the phrase describe?
Stem cell terms can sound interchangeable in advertisements even when the treatments, intended uses, and care settings are different. This distinction matters especially in MS, where treatment decisions require a clinician familiar with the disease and the person’s full medical history.
| Term or approach | What it generally refers to | What to clarify before considering it |
|---|---|---|
| aHSCT | A specialist medical procedure using a patient’s own blood-forming stem cells as part of a treatment plan. | Whether an MS specialist recommends evaluation, center accreditation, eligibility, risks, and follow-up. |
| MSC treatment | A different cell-based approach that may be discussed in regenerative medicine settings. | Whether there is evidence for the specific product and MS use, its regulatory status, and whether an MS specialist supports it. |
| Exosome treatment | A cell-free product approach; it is not a stem cell transplant. | What the product contains, what evidence applies to MS specifically, and what claims are being made. |
| Standard MS care | Neurologist-guided care that may include approved disease-modifying medicines and symptom management. | How any proposed intervention fits with current care and whether it could affect prescribed treatment. |
This table is a starting point for questions, not a treatment recommendation. Do not stop, delay, or change prescribed MS care based on a clinic’s claims or a web article. Discuss any proposed intervention with the clinician coordinating your MS treatment.
How can you evaluate a center?
Look for a center that can answer specific questions without promising a result. A responsible center should explain what it does and does not know, identify the clinician accountable for your care, and encourage you to review the decision with your neurologist. If you are considering aHSCT, ask your neurologist about referral to an accredited center; the National MS Society specifically highlights accreditation for this procedure.
- Ask for the exact treatment name. Find out whether the proposal is aHSCT, an MSC-based intervention, an exosome product, or something else. Ask what cells or material are used and where they come from.
- Ask who will assess you. Confirm that a physician with relevant MS expertise reviews your history, current medications, prior treatment, and individual risks before any decision.
- Ask what evidence applies to your case. Ask whether the information concerns MS itself and the same treatment being offered, rather than another condition or a different product.
- Ask about risks and follow-up. Request a clear explanation of possible complications, monitoring, emergency support, and who will coordinate follow-up with your neurologist.
- Ask for written terms. Understand costs, what is included, refund terms, and whether the treatment is self-pay. Do not rely on verbal assurances about insurance reimbursement.
- Take time to check claims. Be cautious of guaranteed outcomes, claims that a therapy cures MS, pressure to pay immediately, or advice to stop standard care.
Questions about accreditation, team experience, and follow-up are not details to leave until after you travel or pay a deposit. Get answers in writing and share them with your treating neurologist. For background on the distinctions between care settings in the United States and overseas, see this comparison of U.S. and overseas stem cell treatment.
If you are comparing centers in different cities or countries, compare the care pathway, not just the advertised product name. Confirm whether a qualified clinician will assess you before travel, how urgent concerns would be handled after you return, and who will coordinate with your local MS team. Ask whether records, follow-up appointments, and any care instructions will be available in a language you understand. A low advertised price does not tell you whether the evaluation, monitoring, and follow-up you need are included.
It is reasonable to seek another medical opinion before making a major treatment decision. Share the written treatment description with your neurologist and ask what questions remain unanswered. If the provider discourages you from involving your MS clinician, or cannot provide clear information about the treatment and follow-up, do not treat that as a substitute for independent medical advice.
When you compare two providers, make a simple side-by-side record: exact procedure and cell source; clinicians responsible for screening and care; evidence or regulatory information supplied; risk and follow-up plan; and the full out-of-pocket amount. Mark any item that is missing or described only in broad promotional language. Then ask each center the same questions so you can compare answers rather than relying on different sales presentations. The goal is not to select a provider from a checklist alone, but to identify what needs clinical review and whether the proposed care is transparent enough to discuss with your MS team.
What does the evidence say about stem cell approaches for MS?
Evidence depends on the particular treatment and question. Findings about one kind of cell therapy cannot establish that another product or infusion is useful for MS. A paper indexed by the National Institutes of Health is specifically a review of stem cell therapy for multiple sclerosis, while Mayo Clinic describes a research program focused on stem cell therapy in MS and autoimmune neurology. Those sources are reasons to look at the precise approach and the expertise of the care team—not proof that every treatment marketed under the stem-cell label is established or appropriate.
You can read the NIH-hosted review of stem cell therapy for MS and learn about Mayo Clinic’s stem cell therapy program. When reviewing research, check whether it concerns the exact treatment, the same condition, and people with circumstances comparable to yours. A research article or a clinic’s summary should not replace an individual assessment by an MS specialist.
It can help to read a source in layers. First, note what treatment the source actually discusses and whether it is about MS. Next, check whether it describes a study, a review of published work, or a program that conducts research; these are not interchangeable forms of evidence. Finally, write down the limits the source identifies, such as uncertainty about who may benefit or questions that remain unanswered. If a clinic cites a paper, ask for the full reference and how the paper supports the precise service being offered. A citation that mentions stem cells generally does not by itself establish the safety or effectiveness of a different cell source, preparation, dose, or route of administration.
What should you prepare before an MS treatment consultation?
A consultation is more useful when you can identify the specific question you need answered. Before the appointment, write down the treatment name from the provider’s website or offer and note any terms you do not understand. Ask whether the appointment is an educational conversation, a medical assessment, or both. Confirm who will be present and whether that clinician can assess MS-related questions. If the provider cannot explain the treatment clearly, you can take the information away and ask your neurologist before proceeding.
Bring or have available a concise summary of your MS care. This may include your diagnosis history, current and previous medicines, prior procedures, allergies, other health conditions, and contact details for your neurologist. Do not send sensitive medical records through an unverified link or disclose more than is needed before confirming how the information will be used. Ask how the clinic stores records and who can access them.
Use questions that invite a concrete answer rather than a sales claim:
- What is the exact name of the proposed treatment, and what material or cells does it use?
- What is the treatment intended to do for someone with MS, and what evidence supports that specific use?
- What are the known risks, uncertainties, and reasons a person might not be a suitable candidate?
- Who is responsible for screening, administering care, and handling complications?
- What follow-up is provided, and how will the clinic communicate with my neurologist?
- What is the total out-of-pocket cost, what is included, and what happens if I decide not to proceed?
Request the answers and financial terms in writing. Take time to compare them with independent information and review them with the clinician who knows your MS history. A careful provider should allow you to ask questions and seek a second opinion without pressure. If you are being asked to make a rapid payment decision or to stop existing care, treat that as a reason to pause and contact your neurologist.
For a more focused appointment, sort your questions into three groups before you go: medical suitability, practical care, and cost. Under medical suitability, list what you want to know about evidence, risks, and how the approach may fit your MS history. Under practical care, ask who coordinates records, how follow-up happens, and whom to contact if a concern arises. Under cost, ask for a written estimate and what is excluded. This makes it easier to leave with clear answers in each area, even if the right outcome is to wait or seek another opinion.
Is Miami Stem Cell a place to seek MS stem cell treatment?
Miami Stem Cell describes its work as non-surgical regenerative treatments that target the root cause of pain and mobility limitations. Its general stem cell therapy information is not evidence that a particular treatment is appropriate for MS. The clinic should not be confused with an accredited aHSCT center on the basis of the phrase “stem cell” alone, and this article does not claim that Miami Stem Cell provides MS treatment.
If you are in Miami and want to understand what the clinic offers, ask directly whether its services address your specific concern and whether consultation is appropriate. Miami Stem Cell cites 8500+, 17+ years, and a 4.8-star Google review rating; these general business details do not establish effectiveness for MS. Any treatment through the clinic is out-of-pocket and not covered by insurance. Review the clinic’s patient FAQs, and use the about page to learn about the practice. Keep your MS neurologist involved in any care decision.
Ask Miami Stem Cell about its services
Frequently Asked Questions
Is stem cell therapy a cure for MS?
No. Do not rely on claims that any stem cell or exosome treatment cures MS. Discuss potential benefits, limitations, risks, and alternatives for a specific treatment with an MS specialist.
Is aHSCT the same as an MSC or exosome infusion?
No. These terms refer to different approaches. Ask the provider to name the exact treatment and explain how it differs from aHSCT and other cell-based products. Your neurologist can help assess what the proposed approach means for your care.
How do I find an appropriate aHSCT center?
Ask your MS neurologist about referral and evaluation. The National Multiple Sclerosis Society recommends that aHSCT be received at an accredited center and provides general information through its aHSCT page and MS Navigator.
Should I stop my current MS medicine before a consultation?
No. Do not stop or change a prescribed medicine without guidance from the clinician managing your MS. Bring your medication list and treatment history to any consultation.
What is a sensible next step?
Write down the exact treatment you are considering, the questions you still have, and the information the provider gave you. Review those details with your neurologist before making a decision. A careful evaluation can help you distinguish a specialist MS treatment pathway from other services using similar terminology.
Request a FREE Consultation to ask about Miami Stem Cell’s services
For any MS treatment decision, prioritize an individualized discussion with a neurologist experienced in multiple sclerosis and verify the center’s qualifications for the specific procedure.